Hosted on MSN9mon
Teva, Alvotech launch biosimilar against AbbVie’s Humira
A U.S. unit of generic drugmaker Teva Pharmaceutical Industries (NYSE:TEVA) and Luxembourg-based Alvotech (NASDAQ:ALVO) have launched Simlandi, an interchangeable biosimilar version, targeting ...
pharmaphorum11mon
Interchangeable high-concentration Humira approved in US
That is because Alvotech and commercial partner Teva have claimed approval for their Simlandi biosimilar of Humira (adalimumab), which includes the first and so far only fully interchangeable ...
Hosted on MSN11mon
Alvotech/Teva win FDA approval for Humira biosimilar
Alvotech (NASDAQ:ALVO) and partner Teva Pharmaceuticals (NYSE:TEVA) announced Friday the U.S. Food and Drug Administration (FDA) approval for their arthritis injection, Simlandi (adalimumab-ryvk).
Nasdaq23d
FDA To Review Alvotech/Teva's BLA For AVT05, The 1st Biosimilar To Golimumab
The success of AVT05 builds on recent approvals of other biosimilars, such as SIMLANDI and SELARSDI. ALVO closed Friday's (Jan.24, 2025) trading at $12.99 down 0.99%. TEVA closed Friday's (Jan.24 ...